Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Arcovito

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Bioconjugate Chemistry|May 12, 2021
Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer CellsNatalia Pediconi, Francesca Ghirga, Cristina Del Plato, et al.
Frontiers in Immunology|January 1, 2025
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasmsMichele Pitaro, Giovanni Antonini, Alessandro Arcovito, et al.
Iucrj|October 3, 2019
Ligand pathways in neuroglobin revealed by low-temperature photodissociation and docking experimentsChiara Ardiccioni, Alessandro Arcovito, Stefano Della Longa, et al.
Nucleic Acids Research|January 19, 2013
Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNASara Chiarella, Antonella De Cola, Giovanni Luca Scaglione, et al.
EMBO Molecular Medicine|February 1, 2023
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primarySerena Brundu, Virginia Napolitano, Giulia Franzolin, et al.
Pharmaceutics|February 26, 2025
Development of an Innovative Dual Construct for Targeted Drug Delivery in the Oral CavityElena Mazzinelli, Ilaria Favuzzi, Marianna Messina, et al.
Genes|July 27, 2022
Mother and Daughter Carrying of the Same Pathogenic Variant in <i>FGFR2</i> with Discordant PhenotypeFilomena Lo Vecchio, Elisabetta Tabolacci, Veronica Nobile, et al.
International Journal of Molecular Sciences|January 11, 2024
3-O-Methyltolcapone and Its Lipophilic Analogues Are Potent Inhibitors of Transthyretin Amyloidogenesis with High Permeability and Low ToxicityThanalai Poonsiri, Davide Dell'Accantera, Valentina Loconte, et al.
Regenerative Biomaterials|February 6, 2026
A smart nanocomposite bioactive ink for controlled siRNA delivery in calvarial mesenchymal stromal cells as a minimally invasive treatment for craniosynostosisMartina Salvati, Federica Tiberio, Noah Giacon, et al.
International Journal of Biological Macromolecules|April 5, 2025
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapyGiada Tisci, Lenka Rajsiglova, Sandra Bibbo, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Bioconjugate Chemistry|May 12, 2021
Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer CellsNatalia Pediconi, Francesca Ghirga, Cristina Del Plato, et al.
Frontiers in Immunology|January 1, 2025
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasmsMichele Pitaro, Giovanni Antonini, Alessandro Arcovito, et al.
Iucrj|October 3, 2019
Ligand pathways in neuroglobin revealed by low-temperature photodissociation and docking experimentsChiara Ardiccioni, Alessandro Arcovito, Stefano Della Longa, et al.
Nucleic Acids Research|January 19, 2013
Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNASara Chiarella, Antonella De Cola, Giovanni Luca Scaglione, et al.
EMBO Molecular Medicine|February 1, 2023
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primarySerena Brundu, Virginia Napolitano, Giulia Franzolin, et al.
Pharmaceutics|February 26, 2025
Development of an Innovative Dual Construct for Targeted Drug Delivery in the Oral CavityElena Mazzinelli, Ilaria Favuzzi, Marianna Messina, et al.
Genes|July 27, 2022
Mother and Daughter Carrying of the Same Pathogenic Variant in <i>FGFR2</i> with Discordant PhenotypeFilomena Lo Vecchio, Elisabetta Tabolacci, Veronica Nobile, et al.
International Journal of Molecular Sciences|January 11, 2024
3-O-Methyltolcapone and Its Lipophilic Analogues Are Potent Inhibitors of Transthyretin Amyloidogenesis with High Permeability and Low ToxicityThanalai Poonsiri, Davide Dell'Accantera, Valentina Loconte, et al.
Regenerative Biomaterials|February 6, 2026
A smart nanocomposite bioactive ink for controlled siRNA delivery in calvarial mesenchymal stromal cells as a minimally invasive treatment for craniosynostosisMartina Salvati, Federica Tiberio, Noah Giacon, et al.
International Journal of Biological Macromolecules|April 5, 2025
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapyGiada Tisci, Lenka Rajsiglova, Sandra Bibbo, et al.
Pageof 9